Literature DB >> 16388329

Perceptions and attitudes about HFE genotyping among college-age adults.

Bret L Hicken1, Aimee Foshee, Diane C Tucker.   

Abstract

PURPOSE: Examine young adults' attitudes about HFE genotyping.
METHODS: 121 college students read about hemochromatosis, transferrin saturation measurement (iron test), and HFE genotyping. Interest in testing and knowledge and attitudes about genetic testing were assessed. Participants were randomly assigned to predict either their response to a positive HFE genotype (genotype group) or a positive iron test (phenotype group).
RESULTS: 71% preferred the iron test, but most would undergo either test. Learning risk and early detection/prevention were the most commonly perceived benefits; limited information about health and negative emotional consequences were the most commonly perceived disadvantages. The genotype and phenotype groups did not differ in expected worry, perceived severity, perceived risk, and preventability of organ damage. After reading the description provided, participants answered 78% of knowledge questions correctly.
CONCLUSIONS: Young adults view HFE genotyping positively and report few disadvantages, but prefer the iron test for its information about current health. They appear to be receptive to public health screening for hemochromatosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16388329     DOI: 10.1007/s10897-005-4718-y

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  20 in total

Review 1.  Screening for hemochromatosis in primary care settings.

Authors:  S M McDonnell; P D Phatak; V Felitti; A Hover; G D McLaren
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

2.  Haemochromatosis: diagnosis and management after the cloning of the HFE gene.

Authors:  L W Powell; M L Bassett
Journal:  Aust N Z J Med       Date:  1998-04

3.  Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group.

Authors:  D Axworthy; D J Brock; M Bobrow; T M Marteau
Journal:  Lancet       Date:  1996-05-25       Impact factor: 79.321

4.  Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations.

Authors:  N A Press; Y Yasui; S Reynolds; S J Durfy; W Burke
Journal:  Am J Med Genet       Date:  2001-03-01

5.  Communicating genetic risk: pros, cons, and counsel.

Authors:  R T Penson; M V Seiden; K M Shannon; M L Lubratovich; M Roche; B A Chabner; T J Lynch
Journal:  Oncologist       Date:  2000

6.  Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia.

Authors:  V Senior; T M Marteau; T J Peters
Journal:  Soc Sci Med       Date:  1999-06       Impact factor: 4.634

7.  Acceptance of genetic testing in a general population: age, education and gender differences.

Authors:  A R Aro; A Hakonen; M Hietala; J Lönnqvist; P Niemelä; L Peltonen; P Aula
Journal:  Patient Educ Couns       Date:  1997 Sep-Oct

8.  Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.

Authors:  C Foster; D G R Evans; R Eeles; D Eccles; S Ashley; L Brooks; T Cole; J Cook; R Davidson; H Gregory; J Mackay; P J Morrison; M Watson
Journal:  Genet Test       Date:  2004

9.  Attitudes about and psychosocial outcomes of HFE genotyping for hemochromatosis.

Authors:  Bret L Hicken; David A Calhoun; James C Barton; Diane C Tucker
Journal:  Genet Test       Date:  2004

10.  Effects of risk counseling on interest in breast cancer genetic testing for lower risk women.

Authors:  Deborah J Bowen; Wylie Burke; Yutaka Yasui; Anne McTiernan; Dale McLeran
Journal:  Genet Med       Date:  2002 Sep-Oct       Impact factor: 8.822

View more
  1 in total

1.  Ethics of future disclosure of individual risk information in a genetic cohort study: a survey of donor preferences.

Authors:  Kenji Matsui; Reidar K Lie; Yoshikuni Kita; Hirotsugu Ueshima
Journal:  J Epidemiol       Date:  2008-09-08       Impact factor: 3.211

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.